Trappa ethanolamine tablets ; ciclosporin + Placebo ; ciclosporin
Phase 2UNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 31/100
31
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-severe Aplastic Anemia
Conditions
Non-severe Aplastic Anemia
Trial Timeline
Apr 26, 2023 → May 30, 2025
NCT ID
NCT05797623About Trappa ethanolamine tablets ; ciclosporin + Placebo ; ciclosporin
Trappa ethanolamine tablets ; ciclosporin + Placebo ; ciclosporin is a phase 2 stage product being developed by Jiangsu Hengrui Medicine for Non-severe Aplastic Anemia. The current trial status is unknown. This product is registered under clinical trial identifier NCT05797623. Target conditions include Non-severe Aplastic Anemia.
Hype Score Breakdown
Clinical
12
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05797623 | Phase 2 | UNKNOWN |